About Momentum Bioscience
Momentum Bioscience is a Healthcare company based in Cardiff (United Kingdom) founded in 2008. Momentum Bioscience has raised $5.75 million across 2 funding rounds from investors including IIG PLC. The company has 12 employees. Momentum Bioscience offers products and services including SepsiSTAT System and Rapid Phenotypic AST. Its focus areas include Life Sciences, Infectious Diseases, In Vitro Diagnostic Tests and Diversified. Its legal entity is MOMENTUM BIOSCIENCE LIMITED.
Company details
Developer of diagnostic solutions for the detection of infectious diseases. Its proprietary platform Enzymatic Template Generation Amplification (ETGA) detects microbial infections by measuring nucleic acid modifying enzymes. The companys flagship product is Cognition is based on ETGA technology.
- Headquarters Cardiff, United Kingdom
- Employees 12
- SectorsHealthcare
- Email••••••••
- Website momentumbio.co.uk
- Social LinkedIn
- Legal Name Momentum Bioscience Limited
- Date of Incorporation 17 Oct, 2005
- Jurisdiction CARDIFF, WALES
- Total Equity Funding$5.75M (USD)
in 2 rounds
- Latest Funding Round$5.4M (USD), Series A
Sep 2021
- Investors
- Employee Count12
Products & Services of Momentum Bioscience
Momentum Bioscience offers a comprehensive portfolio of products and services, including SepsiSTAT System and Rapid Phenotypic AST.
Enables rapid detection and testing of bloodstream infections from blood samples.
Accelerates antibiotic susceptibility results for sepsis treatment.
Funding Insights of Momentum Bioscience
Momentum Bioscience has successfully raised a total of $5.75M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $5.4 million completed in September 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5.75M
- Total Rounds 2
- Last Round Series A — $5.4M
- First Round $355,000
(Sep 2011)
- Investors Count 1
All 2 funding rounds of Momentum Bioscience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2021 | $5.4M | Series A | – | – | |
| Sep 2011 | $355,000 | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in Momentum Bioscience
Momentum Bioscience has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include IIG PLC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are directed by IIG toward life sciences startups. | 2020 | iigplc.com | London, United Kingdom |
Investor details for Momentum Bioscience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Momentum Bioscience
5 people are tracked at Momentum Bioscience (3 in leadership, 2 in team); the tracked headcount is 12.
| Name | Role | Group |
|---|---|---|
Daniel Lockhart | Head Of Research And Development | Leadership |
Sumi Thaker | Chief Executive Officer | Leadership |
Bill Mullen | Chief Scientific Officer | Leadership |
Cyrine Mestiri | Senior Development Scientist | Team |
James Turner | Principal Development Scientist | Team |
Complete people profiles for Momentum Bioscience
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Momentum Bioscience
3 dated milestones of Momentum Bioscience across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Momentum Bioscience is founded.
- Funding First funding round of $355K.
- Funding Latest funding round, Series A, of $5.4M.
Top companies in Genomics & Gene Therapy Platforms
2 companies that operate in the same segment as Momentum Bioscience (Genomics & Gene Therapy Platforms) in United Kingdom, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Momentum Bioscience
Complete news archive for Momentum Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Momentum Bioscience
Momentum Bioscience was founded in 2008 and raised its 1st funding round 3 years after it was founded.
Momentum Bioscience is headquartered in Cardiff, United Kingdom. It is registered at Cardiff, Wales, United Kingdom.
Momentum Bioscience is a funded company, having raised a total of $5.75M across 2 funding rounds to date. The company's 1st funding round was a Seed of $355K, raised on Sep 2011.
Momentum Bioscience has 12 employees.
Developer of diagnostic solutions for the detection of infectious diseases. Its proprietary platform Enzymatic Template Generation Amplification (ETGA) detects microbial infections by measuring nucleic acid modifying enzymes. The companys flagship product is Cognition is based on ETGA technology.
Momentum Bioscience offers SepsiSTAT System and Rapid Phenotypic AST.
Momentum Bioscience has 1 investor. Key investors include IIG PLC.
Momentum Bioscience operates through Momentum Bioscience Limited.